WO2008016984A3 - Vaccin polysaccharide et utilisations de celui-ci - Google Patents

Vaccin polysaccharide et utilisations de celui-ci Download PDF

Info

Publication number
WO2008016984A3
WO2008016984A3 PCT/US2007/074985 US2007074985W WO2008016984A3 WO 2008016984 A3 WO2008016984 A3 WO 2008016984A3 US 2007074985 W US2007074985 W US 2007074985W WO 2008016984 A3 WO2008016984 A3 WO 2008016984A3
Authority
WO
WIPO (PCT)
Prior art keywords
polysaccharide vaccine
polysaccharide
compositions
alp3
elicit
Prior art date
Application number
PCT/US2007/074985
Other languages
English (en)
Other versions
WO2008016984A2 (fr
Inventor
Lawrence C Madoff
Lawrence Paoletti
Dennis L Kasper
Catherine Lachenauer
Original Assignee
Brigham & Womens Hospital
Lawrence C Madoff
Lawrence Paoletti
Dennis L Kasper
Catherine Lachenauer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital, Lawrence C Madoff, Lawrence Paoletti, Dennis L Kasper, Catherine Lachenauer filed Critical Brigham & Womens Hospital
Publication of WO2008016984A2 publication Critical patent/WO2008016984A2/fr
Publication of WO2008016984A3 publication Critical patent/WO2008016984A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne des compositions antigènes comprenant un polypeptide ALP3 en association avec un polysaccharide tel qu'un polysaccharide des streptocoques du groupe B, et des procédés d'utilisation des compositions pour obtenir une réponse immunitaire.
PCT/US2007/074985 2006-08-01 2007-08-01 Vaccin polysaccharide et utilisations de celui-ci WO2008016984A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83500306P 2006-08-01 2006-08-01
US60/835,003 2006-08-01

Publications (2)

Publication Number Publication Date
WO2008016984A2 WO2008016984A2 (fr) 2008-02-07
WO2008016984A3 true WO2008016984A3 (fr) 2008-11-20

Family

ID=38997841

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/074985 WO2008016984A2 (fr) 2006-08-01 2007-08-01 Vaccin polysaccharide et utilisations de celui-ci

Country Status (1)

Country Link
WO (1) WO2008016984A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3004631A1 (fr) * 2015-12-30 2017-07-06 Minervax Aps Complexe immunogene provoquant une immunite protectrice contre un streptocoque du groupe b

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
LACHENAUER ET AL.: "A Protective Surface Protein from Type V Group B Streptococci Shares N-Terminal Sequence Homology with the Alpha C Protein", INFECTION AND IMMUNITY, vol. 64, no. 10, October 1996 (1996-10-01), pages 4255 - 4260 *
LACHENAUER ET AL.: "Mosaicism in the Alpha-Like Protein Genes of Group B Streptococci", PNAS, vol. 97, no. 17, 15 August 2000 (2000-08-15), pages 9630 - 9635, XP002152238, DOI: doi:10.1073/pnas.97.17.9630 *
MAELAND ET AL.: "Antigenic Determinants of Alpha-Like Proteins of the Streptococcus agalactiae", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, vol. 11, no. 6, November 2004 (2004-11-01), pages 1035 - 1039 *
PAOLETTI ET AL.: "Group B Streptococcus Type II Polysaccharide-Tetanus Toxois Conjugate Vaccine", INFECTION AND IMMUNITY, vol. 60, no. 10, October 1992 (1992-10-01), pages 4009 - 4014, XP000601510 *
WESSELS ET AL.: "Immunogenicity in Animals of a Polysaccharide-Protein Conjugate Vaccine against Ype III Group B Streptococcus", J. CLIN. INVEST., vol. 86, November 1990 (1990-11-01), pages 1428 - 1433, XP002546281 *

Also Published As

Publication number Publication date
WO2008016984A2 (fr) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2009016515A3 (fr) Compositions comprenant des antigènes pneumococciques
WO2010119343A8 (fr) Compositions pour l'immunisation contre staphylococcus aureus
WO2009039229A3 (fr) Procédé pour conférer une réponse immune protectrice à un norovirus
MX2009001412A (es) Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas.
MY150706A (en) Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
WO2007120673A3 (fr) Peptides wt1 immunogènes et leurs méthodes d'utilisation
WO2013006842A3 (fr) Compositions immunogènes et leurs utilisations
WO2009128950A3 (fr) Mutants par délétion de la flagelline et procédés d’utilisation
WO2007109812A3 (fr) Composes de potentialisation immunitaire
WO2013054199A3 (fr) Antigènes de cmv et leurs utilisations
WO2008039390A3 (fr) Compositions et procédés pour améliorer la réponse immunitaire à l'aide des chitosanes
WO2007067681A3 (fr) Compositions et méthodes immunostimulatoires
WO2008100598A3 (fr) Procédé d'amélioration de la réponse des cellules t
WO2007092792A3 (fr) Vaccin à base de levure destiné à induire une réponse immunitaire
WO2013132452A3 (fr) Compositions de neisseria meningitidis et procédés associés
MX2019001761A (es) Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis.
WO2014136064A3 (fr) Polypeptides immunogènes de fusion
WO2006071989A3 (fr) Methodes de declenchement, d'accentuation et de maintien de reponses immunitaires contre des epitopes restreints du cmh de classe i a des fins prophylactiques ou therapeutiques
WO2015175355A8 (fr) Compositions et procédés d'augmentation de l'immunogénicité de conjugués polysaccharide-protéine
TW200603825A (en) Prrsv subunit vaccines
AU2013331781A8 (en) Immunogenic composition comprising 1 or more Streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising Protein E and/or PilA from Haemophilus influenzae.
WO2008148057A3 (fr) Compositions et procédés pour améliorer la réponse immunitaire à des vaccins
WO2010103017A3 (fr) Conjugués haptène-support liés à des toxines bactériennes et ayant un peptide signal comme support, et leur utilisation dans des compositions immunogènes
WO2007115059A3 (fr) Vaccin anti-streptocoques
WO2007078879A3 (fr) Compositions de lipopeptides et leurs procédés d'utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07813657

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07813657

Country of ref document: EP

Kind code of ref document: A2